Is Alnylam Stock Poised For More Gains After A Stellar 50% Rise In A Month?
- Tuesday, August 23, 2022, 7:18
- Market
- Add a comment
Alnylam Pharmaceuticals stock (NASDAQ: ALNY), a pharmaceutical company focused on RNA interference therapeutics for genetically defined diseases, has seen a significant rise of 51% in a month.
About the Author
admin123 has written 23415 stories on this site.
